Literature DB >> 2710011

Chlordiazepoxide metabolite accumulation in liver disease.

K Barton1, P W Auld, M G Scott, D P Nicholls.   

Abstract

Chlordiazepoxide 40mg daily was used to prevent delerium tremens in a 64-year-old female with alcoholic liver disease. After 20 days, the drug was stopped because of the onset of progressive drowsiness. The kinetics of chloridazepoxide were within the predicted range for patients with liver disease, but the elimination half-lives of desmethylchlordiazepoxide and demoxepam were greatly prolonged at 346 hours and 150 hours, respectively. It is suggested that metabolite accumulation may have contributed to the coma, which is an unusual reaction to chlordiazepoxide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710011     DOI: 10.1007/BF03259904

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  14 in total

Review 1.  Alcohol intoxication and withdrawal.

Authors:  J Koch-Weser; E M Sellers; H Kalant
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

2.  A critique of overemphasis on side effects with the psychotropic drugs: an analysis of 18,000 chlordiazepoxide-treated cases.

Authors:  S E Svenson; R G Hamilton
Journal:  Curr Ther Res Clin Exp       Date:  1966-10

3.  Biological half-life of chlordiazepoxide and its metabolite, demoxepam, in man.

Authors:  M A Schwartz; E Postma; Z Gaut
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

4.  Treatment of the acute alcohol withdrawal state: a comparison of four drugs.

Authors:  S C Kaim; C J Klett; B Rothfeld
Journal:  Am J Psychiatry       Date:  1969-06       Impact factor: 18.112

5.  Side effect of chlordiazepoxide.

Authors:  D Benor
Journal:  J Clin Pharmacol J New Drugs       Date:  1967 May-Jun

6.  Plasma concentrations of benzodiazepines.

Authors:  A J Bond; D M Hailey; M H Lader
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

8.  An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease.

Authors:  C A Naranjo; U Busto; E Janecek; I Ruiz; C A Roach; K Kaplan
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

9.  Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).

Authors:  R K Roberts; G R Wilkinson; R A Branch; S Schenker
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

10.  Halazepam in the management of acute alcohol withdrawal syndrome.

Authors:  J Mendels; T W Wasserman; T J Michals; E W Fine
Journal:  J Clin Psychiatry       Date:  1985-05       Impact factor: 4.384

View more
  1 in total

Review 1.  Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.

Authors:  B K Wagner; D A O'Hara
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.